Health Populi

MARCH 19, 2019

Payors have begun to recognize the value of nudging consumers toward over-the-counter products under Medicare Advantage plans. Edelman’s health industry segments for this study are pharma, consumer health, insurance, biotech/life science, and hospitals. Tell your health tech story,” Peter urged.

BioTech 149

BioTech Life Science Leadership Medicare 149

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. One of the core issues is that the industry has become single threaded in its sourcing strategy. The new year will bear witness to great innovation in biotech in the precision oncology space. Dr. Ofer Sharon, CEO at OncoHost.

Health IT 91

Health IT Pharmaceuticals Drug Development Life Science 91

Health Populi

JUNE 18, 2020

Here’s one of many looks into the issue , in which I’m quoted on scenarios for Gilead’s possible pricing strategies for remdesivir. In today’s pharma/biotech market, the “specialty” label is given to many therapies: for products addressing rare diseases, risk-management, and above all, high cost drugs.

BioTech 191

BioTech Medicare Life Science Telehealth 191

Health Populi

MAY 19, 2019

They don’t tend to shop around for health care or be super-engaged in their care, probably because they tend to be older and more likely to be covered by Medicare. They may be threatened by a call for “Medicare for All” given their affection for the program. That’s an interesting conundrum to consider.

Life Science 149

Life Science BioTech Medicare Medical Billing 149